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Purpose: Stem cell therapy has emerged as a promising approach for
orthopaedic treatment because of their potential ability of regenerating
damaged tissues. One of the challenges is the ability to track implanted
cells noninvasively following implantation. Several papers have addressed
the topic of visualizing and tracking transplanted cells non-invasively using
superparamagnetic iron oxide (SPIO) in magnetic resonance imaging (MRI).
The aim of this study is to determine if SPIO internalization interferes with
the chondrogenic differentiation ability of human mesenchymal stem cells
(MSCs) seeded in collagen sponge biomaterials.
Methods: Human bone marrow-derived mesenchymal stem cells (hMSCs)
were expanded in monolayer and are ﬁrst labeled with different SPIO
concentrations between 0 and 200 μg/ml Fe. The endorem-labeled hMSCs
were cultured into collagen sponge during 28 days with or without TGF-β1
to induce chondrogenic differentiation. Chondrogenic gene expression (coll
2, coll 1, coll 10, aggrecan, versican, COMP, sox 9, osteocalcin, alkaline
phosphatase) were investigated by using real-time quantitative RT-PCR.
Synthesized extracellular matrix inside sponge was assessed histologically
(proteoglycan and collagen content, SPIO detection) and immunohisto-
chemically (coll 1, coll 2).
Results: TGF-β1 induced an increase of chondrogenic gene expression (col
2, aggrecan, Sox 9, COMP) and an abundant synthesized extracellular ma-
trix inside sponge. SPIO labeling of MSC interfered with chondrogenesis: a
dose-dependent decrease of gene expression such as aggrecan, Coll 1, coll 2,
Sox 9, COMP was observed in SPIO labeled cells. Histologically, the quality
and the quantity of synthesized matrix were affected by SPIO labeling in
a dose dependant manner. The low concentration 12.5 μg/ml Fe induced a
small decrease of proteoglycan and collagen 2 content. From 50 μg/ml Fe,
a marked inhibition of chondrogenesis was observed: extracellular matrix
was poor in proteoglycan and collagen contents.
Conclusions: We observed a dose-dependent deleterious effect of SPIO
concentration on the chondrogenic differentiation of human MSCs. The use
of SPIO labeling to monitor cell-based therapies in MSC driven articular
cartilage engineering requires very low SPIO concentration to minimize
signiﬁcant inﬂuence cell metabolism.
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INFLUENCE OF CARTILAGE MICROENVIRONMENT ON CHONDROGENIC
DIFFERENTIATION OF HUMANMESENCHYMAL STEM CELLS
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Univ. Regensburg, Regensburg, Germany
Purpose: We want to analyse the impact of articular cartilage explant
surfaces on chondrogenic differentiation of mesenchymal stem cells (MSCs)
and properties of regenerated tissue. Furthermore, we test whether direct
cell-to-cell contact between differentiated chondrocytes and undifferen-
tiated MSCs in these experimental set ups will enhance differentiation
and improve hyaline cartilage like quality and biomechanical properties of
regenerated tissue.
This study is designed to identify microenvironmental conditions which
promote, prevent or interfere with chondrogenic differentiation of MSCs
and to analyse their impact on molecular properties and quality of regener-
ated tissue. The aim is a better understanding of microenvironmental cues
and the modulating inﬂuence of neighbouring cells and tissue interfaces on
chondrogenic differentiation of chondroprogenitor cells.
Methods: Articular cartilage explants and chondrocytes for our repro-
ducible coculture regimens between chondrocytes and the chondral in-
terface were prepared from osteoarthritic knee samples while MSCs were
purchased from Lonza. MSCs/chondrocytes alone or mixed (1:1) were
embedded in a ﬁbrin-gel, providing a 3D environment and applied onto
the cartilage explant surface. Cocultures were kept for up to 28 days in
chondrogenic medium before being processed for analysis of gene expres-
sion (qPCR) and morphology (histology/immunohistochemistry) after 7, 14,
21 and 28 days. Chondrogenic differentiation was analyzed by staining
differentiation and dedifferentiation marker as aggrecan and collagens I, II
and III, supported by quantitative real-time PCR of COL1A1, COL2A1, COL3A1
and SOX9. Additionally, we quantiﬁed intracellular located collagens I and
II after 28 days by using ELISAs. Viability and proliferation ability of
cocultured cells was tested using a LDH-based assay and PCNA staining,
respectively.
Results: Vitality of chondrocytes and/or MSCs grown in a ﬁbrin-gel applied
onto an articular cartilage surface was not altered during the culture time
period and a residual proliferation potential was detected in all culture
conditions of our experimental setups. A chondrogenic gene expression
proﬁle was veriﬁed in MSCs and/or chondrocytes in all culture conditions.
Gene expression of the dedifferentiation marker COL1A1 was decreased
while the differentiation marker SOX9 and COL2A1 showed an increased
gene expression in comparison to MSCs/chondrocytes in monolayer. In
our coculture system with cartilage explants we have detected a reduced
protein amount of collagen I and III in MSCs in comparison to MSCs grown
in ﬁbrin-gel alone. Chondrocytes cultivated together with cartilage explants
produced less collagen I and II in comparison to chondrocytes grown in
ﬁbrin-gel and a mixture of chondrocytes and MSCs grown together with
cartilage explants expressed less collagen I than cells grown in ﬁbrin-gel
alone.
Conclusions: The 3D-environment of the ﬁbrin-gel has a positive effect
on the chondrogenic phenotype of chondrocytes and the chondrogenic
differentiation capability of MSCs. The results of our coculture system
with cartilage explants indicated an inhibition of collagens I, II and III
presumably caused by cartilage - derived factors such as PtHrP, bFGF or
pro-inﬂammatory cytokines of the Il-and TNF-family. A better understand-
ing of this modulating inﬂuence of microenvironmental cues of cartilage
on chondrogenic differentiation of MSCs could lead to a potent strategy for
cell-based regeneration of either traumatic or osteoarthritic focal articular
cartilage lesions.
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Purpose: The objective of the study is to use bioactive matrices to enhance
the potency of bone morphogenetic protein 2 (BMP2), a heparan binding
growth factor, and induce matrix turnover in damaged articular cartilage.
Methods: Hyaluronic acid (HA) covalently bound to a domain of perlecan
carrying heparan sulfate chains (HA-PlnD1) was used as a novel delivery
system for controlled release of BMP2 to stimulate expression of extracel-
lular matrix by articular cartilage cells in a mouse model of osteoarthritis
(OA). OA-like damages that were induced by papain (1%) were treated
seven days later by injecting intra-articularly either HA-PlnD1 preincu-
bated with BMP2, HA-PlnD1 alone, or saline. The knees were dissected
at day 7 and day 14 following these treatments and analyzed using both
histological and immunohistochemical procedures.
Results: Knees treated with HA-PlnD1/BMP2 had lesser damage and
showed increased proteoglycan expression when compared to control
knees. In addition, the HA-PlnD1/BMP2-treated knees showed enhanced
detection of aggrecan by immunohistochemistry. Improvement is evident
from the attenuated damage and increased matrix maintenance in treated
knees versus control conditions. Ongoing work will ascertain whether
this is due to increased transcript levels encoding matrix components or
inhibition of degradative enzymes.
Conclusions: HA-PlnD1 biomatrices thus act as an eﬃcient in vivo delivery
system for BMP2 and prolong the action of BMP2 in healing murine
articular cartilage. Ultimately, HA-PlnD1/BMP2 may serve as a therapeutic
agent for inducing repair of partial thickness cartilage lesions, preventing
the onset of irreversible OA. (Supported by NIH COBRE P20 RR016458 to
CKS).
